Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.
Identifieur interne : 000022 ( PubMed/Curation ); précédent : 000021; suivant : 000023Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.
Auteurs : Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisSource :
- The Journal of infectious diseases [ 1537-6613 ] ; 2018.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Démographie, Enfant, Enfant d'âge préscolaire, Femelle, Grippe humaine (immunologie), Grippe humaine (virologie), Grippe humaine (épidémiologie), Hong Kong (épidémiologie), Humains, Immunité, Jeune adulte, Mâle, Nourrisson, Pandémies, Sous-type H2N2 du virus de la grippe A (immunologie), Sous-type H2N2 du virus de la grippe A (isolement et purification), Sujet âgé, Sujet âgé de 80 ans ou plus, État de New York (épidémiologie), Études séroépidémiologiques, Évaluation des risques.
- MESH :
- immunologie : Grippe humaine, Sous-type H2N2 du virus de la grippe A.
- isolement et purification : Sous-type H2N2 du virus de la grippe A.
- virologie : Grippe humaine.
- épidémiologie : Grippe humaine, Hong Kong, État de New York.
- Adolescent, Adulte, Adulte d'âge moyen, Animaux, Démographie, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Immunité, Jeune adulte, Mâle, Nourrisson, Pandémies, Sujet âgé, Sujet âgé de 80 ans ou plus, Études séroépidémiologiques, Évaluation des risques.
- Wicri :
- geographic : Hong Kong.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Child, Child, Preschool, Demography, Female, Hong Kong (epidemiology), Humans, Immunity, Infant, Influenza A Virus, H2N2 Subtype (immunology), Influenza A Virus, H2N2 Subtype (isolation & purification), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (virology), Male, Middle Aged, New York (epidemiology), Pandemics, Risk Assessment, Seroepidemiologic Studies, Young Adult.
- MESH :
- geographic , epidemiology : Hong Kong, New York.
- epidemiology : Influenza, Human.
- immunology : Influenza A Virus, H2N2 Subtype, Influenza, Human.
- isolation & purification : Influenza A Virus, H2N2 Subtype.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Aged, 80 and over, Animals, Child, Child, Preschool, Demography, Female, Humans, Immunity, Infant, Male, Middle Aged, Pandemics, Risk Assessment, Seroepidemiologic Studies, Young Adult.
Abstract
Influenza A pandemics cause significant mortality and morbidity. H2N2 viruses have caused a prior pandemic, and are circulating in avian reservoirs. The age-related frequency of current population immunity to H2 viruses was evaluated.
DOI: 10.1093/infdis/jiy291
PubMed: 29762672
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000022
Links to Exploration step
pubmed:29762672Curation
No country items
Ranawaka A P M. Perera<affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.</title><author><name sortKey="Babu, Tara M" sort="Babu, Tara M" uniqKey="Babu T" first="Tara M" last="Babu">Tara M. Babu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Perera, Ranawaka A P M" sort="Perera, Ranawaka A P M" uniqKey="Perera R" first="Ranawaka A P M" last="Perera">Ranawaka A P M. Perera</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Wu, Joseph T" sort="Wu, Joseph T" uniqKey="Wu J" first="Joseph T" last="Wu">Joseph T. Wu</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Fitzgerald, Theresa" sort="Fitzgerald, Theresa" uniqKey="Fitzgerald T" first="Theresa" last="Fitzgerald">Theresa Fitzgerald</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Nolan, Carolyn" sort="Nolan, Carolyn" uniqKey="Nolan C" first="Carolyn" last="Nolan">Carolyn Nolan</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Krauss, Scott" sort="Krauss, Scott" uniqKey="Krauss S" first="Scott" last="Krauss">Scott Krauss</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis</wicri:cityArea></affiliation></author><author><name sortKey="Treanor, John J" sort="Treanor, John J" uniqKey="Treanor J" first="John J" last="Treanor">John J. Treanor</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:29762672</idno><idno type="pmid">29762672</idno><idno type="doi">10.1093/infdis/jiy291</idno><idno type="wicri:Area/PubMed/Corpus">000022</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000022</idno><idno type="wicri:Area/PubMed/Curation">000022</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000022</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.</title><author><name sortKey="Babu, Tara M" sort="Babu, Tara M" uniqKey="Babu T" first="Tara M" last="Babu">Tara M. Babu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Perera, Ranawaka A P M" sort="Perera, Ranawaka A P M" uniqKey="Perera R" first="Ranawaka A P M" last="Perera">Ranawaka A P M. Perera</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Wu, Joseph T" sort="Wu, Joseph T" uniqKey="Wu J" first="Joseph T" last="Wu">Joseph T. Wu</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Fitzgerald, Theresa" sort="Fitzgerald, Theresa" uniqKey="Fitzgerald T" first="Theresa" last="Fitzgerald">Theresa Fitzgerald</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Nolan, Carolyn" sort="Nolan, Carolyn" uniqKey="Nolan C" first="Carolyn" last="Nolan">Carolyn Nolan</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author><author><name sortKey="Krauss, Scott" sort="Krauss, Scott" uniqKey="Krauss S" first="Scott" last="Krauss">Scott Krauss</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis</wicri:cityArea></affiliation></author><author><name sortKey="Treanor, John J" sort="Treanor, John J" uniqKey="Treanor J" first="John J" last="Treanor">John J. Treanor</name><affiliation wicri:level="2"><nlm:affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">État de New York</region></placeName><wicri:cityArea>Department of Infectious Diseases, University of Rochester Medical Center</wicri:cityArea></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong.</nlm:affiliation><wicri:noCountry code="subField">The University of Hong Kong</wicri:noCountry></affiliation></author></analytic><series><title level="j">The Journal of infectious diseases</title><idno type="eISSN">1537-6613</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Demography</term><term>Female</term><term>Hong Kong (epidemiology)</term><term>Humans</term><term>Immunity</term><term>Infant</term><term>Influenza A Virus, H2N2 Subtype (immunology)</term><term>Influenza A Virus, H2N2 Subtype (isolation & purification)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (virology)</term><term>Male</term><term>Middle Aged</term><term>New York (epidemiology)</term><term>Pandemics</term><term>Risk Assessment</term><term>Seroepidemiologic Studies</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Démographie</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (virologie)</term><term>Grippe humaine (épidémiologie)</term><term>Hong Kong (épidémiologie)</term><term>Humains</term><term>Immunité</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Pandémies</term><term>Sous-type H2N2 du virus de la grippe A (immunologie)</term><term>Sous-type H2N2 du virus de la grippe A (isolement et purification)</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>État de New York (épidémiologie)</term><term>Études séroépidémiologiques</term><term>Évaluation des risques</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Hong Kong</term><term>New York</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term><term>Sous-type H2N2 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A Virus, H2N2 Subtype</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Influenza A Virus, H2N2 Subtype</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Sous-type H2N2 du virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Grippe humaine</term><term>Hong Kong</term><term>État de New York</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Demography</term><term>Female</term><term>Humans</term><term>Immunity</term><term>Infant</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Risk Assessment</term><term>Seroepidemiologic Studies</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Animaux</term><term>Démographie</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Immunité</term><term>Jeune adulte</term><term>Mâle</term><term>Nourrisson</term><term>Pandémies</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études séroépidémiologiques</term><term>Évaluation des risques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Hong Kong</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Influenza A pandemics cause significant mortality and morbidity. H2N2 viruses have caused a prior pandemic, and are circulating in avian reservoirs. The age-related frequency of current population immunity to H2 viruses was evaluated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">29762672</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>218</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>08</Month><Day>24</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J. Infect. Dis.</ISOAbbreviation></Journal><ArticleTitle>Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.</ArticleTitle><Pagination><MedlinePgn>1054-1060</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiy291</ELocationID><Abstract><AbstractText Label="Background">Influenza A pandemics cause significant mortality and morbidity. H2N2 viruses have caused a prior pandemic, and are circulating in avian reservoirs. The age-related frequency of current population immunity to H2 viruses was evaluated.</AbstractText><AbstractText Label="Methods">Hemagglutinin inhibition (HAI) assays against historical human and recent avian influenza A(H2N2) viruses were performed across age groups in Rochester, New York, and Hong Kong, China. The impact of existing cross-reactive HAI immunity on the effective reproduction number was modeled.</AbstractText><AbstractText Label="Results">One hundred fifty individual sera from Rochester and 295 from Hong Kong were included. Eighty-five percent of patients born in Rochester and Hong Kong before 1968 had HAI titers ≥1:40 against A/Singapore/1/57, and >50% had titers ≥1:40 against A/Berkeley/1/68. The frequency of titers ≥1:40 to avian H2N2 A/mallard/England/727/06 and A/mallard/Netherlands/14/07 in subjects born before 1957 was 62% and 24%, respectively. There were no H2 HAI titers >1:40 in individuals born after 1968. These levels of seroprevalence reduce the initial reproduction number of A/Singapore/1/1957 or A/Berkeley/1/68 by 15%-20%. A basic reproduction number (R0) of the emerging transmissible virus <1.2 predicts a preventable pandemic.</AbstractText><AbstractText Label="Conclusions">Population immunity to H2 viruses is insufficient to block epidemic spread of H2 virus. An H2N2 pandemic would have lower impact in those born before 1968.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Tara M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perera</LastName><ForeName>Ranawaka A P M</ForeName><Initials>RAPM</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Joseph T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzgerald</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>Carolyn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krauss</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treanor</LastName><ForeName>John J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of Rochester Medical Center, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peiris</LastName><ForeName>Malik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM088558</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN272201400006C</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053121" MajorTopicYN="N">Influenza A Virus, H2N2 Subtype</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009518" MajorTopicYN="N" Type="Geographic">New York</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>03</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29762672</ArticleId><ArticleId IdType="pii">4995521</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiy291</ArticleId><ArticleId IdType="pmc">PMC6107991</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMC Infect Dis. 2017 May 11;17(1):337</Citation><ArticleIdList><ArticleId IdType="pubmed">28494805</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2011 Mar 10;471(7337):157-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21390107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Dec 13;362(9400):1959-66</Citation><ArticleIdList><ArticleId IdType="pubmed">14683655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull Hist Med. 2002 Spring;76(1):105-15</Citation><ArticleIdList><ArticleId IdType="pubmed">11875246</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2012 Jan 29;18(2):274-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22286307</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2013 Mar;20(3):245-6</Citation><ArticleIdList><ArticleId IdType="pubmed">23463305</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2015 Oct 15;212(8):1191-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25858957</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Feb;89(4):2442-7</Citation><ArticleIdList><ArticleId IdType="pubmed">25505070</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2009 Sep 1;183(5):3294-301</Citation><ArticleIdList><ArticleId IdType="pubmed">19648276</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2014 Sep 04;14:480</Citation><ArticleIdList><ArticleId IdType="pubmed">25186370</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1958 Apr 19;1(7025):810-4</Citation><ArticleIdList><ArticleId IdType="pubmed">13526279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2013 Feb;9(2):405-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23291930</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2008 Mar 25;5(3):e74</Citation><ArticleIdList><ArticleId IdType="pubmed">18366252</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Apr 03;10(4):e1004054</Citation><ArticleIdList><ArticleId IdType="pubmed">24699693</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Vaccine Immunol. 2011 Aug;18(8):1205-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21653743</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2013 Oct;19(10):1305-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24056771</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Top Microbiol Immunol. 2014;385:119-36</Citation><ArticleIdList><ArticleId IdType="pubmed">25085014</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2014 Jan;88(2):1175-88</Citation><ArticleIdList><ArticleId IdType="pubmed">24227848</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 1993 Jun;194(2):781-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7684877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull World Health Organ. 1966;34(6):885-93</Citation><ArticleIdList><ArticleId IdType="pubmed">5296537</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(7):e39435</Citation><ArticleIdList><ArticleId IdType="pubmed">22815705</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000022 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000022 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:29762672
|texte= Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:29762672" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |